Y0002225

Regorafenib for FP system suitability

CRS, European Pharmacopoeia (EP) Reference Standard

• Sinonimo/i: Regorafenib monohydrate, 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide monohydrate
• Formula empirica (notazione di Hill): C₂₁H₁₅ClF₄N₄O₃ · H₂O
• Numero CAS: 1019206-88-2
• Peso molecolare: 500.83
• Codice UNSPSC: 41116107
• NACRES: NA.24

Proprietà

• Famiglia di API: regorafenib
• Produttore/marchio commerciale: EDQM
• Temperatura di conservazione: 2-8°C
• InChI: 1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2; ZOPOQLDXFHBOIH-UHFFFAOYSA-N

Descrizione

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Regorafenib for FP system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Informazioni sulla sicurezza

• Pittogrammi: GHS08,GHS09
• Avvertenze: Warning
• Indicazioni di pericolo: H361fd,H373,H410
• Consigli di prudenza: P201 - P202 - P260 - P273 - P280 - P308 + P313
• Classi di pericolo: Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2
• Organi bersaglio: Liver
• Codice della classe di stoccaggio: 11 - Combustible Solids
• Classe di pericolosità dell'acqua (WGK): WGK 3
• Punto d’infiammabilità (°F): Not applicable
• Punto d’infiammabilità (°C): Not applicable